Is gene therapy the answer to an untreatable form of macular degeneration?
There is a shocking lack of attention given to racemization in drug discovery, despite it having huge implications on the efficacy – and safety – of drugs. We hope the tool we have developed will be the first step towards change.
Sitting Down With… Carolyn Bertozzi, Anne T. and Robert M. Bass Professor of Chemistry, and Professor (by courtesy) of Chemical & Systems Biology and Radiology,Stanford University, USA.
A tool to predict racemization could help prevent drug discovery dead ends
Stem cells hold great promise, but is it the cells we really need?
What are the realities of translating exciting cell and gene therapy research into something more tangible?
Stem cells with a seasonal theme.
The gates for gene and cell therapies are open, and RNAi technology could be a serious contender
Mutations in four main genes influence survival rates of pancreatic adenocarcinoma patients
Sherry Dunbar and Rana Gunjot
As molecular diagnostic methods evolve, so does our approach to microbial testing…
Send me the latest from The Translational Scientist.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.